Hypothalamic proteoglycan syndecan-3 is a novel cocaine addiction resilience factor

25Citations
Citations of this article
37Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Proteoglycans like syndecan-3 have complex signaling roles in addition to their function as structural components of the extracellular matrix. Here, we show that syndecan-3 in the lateral hypothalamus has an unexpected new role in limiting compulsive cocaine intake. In particular, we observe that syndecan-3 null mice self-administer greater amounts of cocaine than wild-type mice. This effect can be rescued by re-expression of syndecan-3 in the lateral hypothalamus with an adeno-associated viral vector. Adeno-associated viral vector delivery of syndecan-3 to the lateral hypothalamus also reduces motivation for cocaine in normal mice. Syndecan-3 limits cocaine intake by modulating the effects of glial-cell-line-derived neurotrophic factor, which uses syndecan-3 as an alternative receptor. Our findings indicate syndecan-3-dependent signaling as a novel therapeutic target for the treatment of cocaine addiction. © 2013 Macmillan Publishers Limited. All rights reserved.

Cite

CITATION STYLE

APA

Chen, J., Repunte-Canonigo, V., Kawamura, T., Lefebvre, C., Shin, W., Howell, L. L., … Sanna, P. P. (2013). Hypothalamic proteoglycan syndecan-3 is a novel cocaine addiction resilience factor. Nature Communications, 4. https://doi.org/10.1038/ncomms2955

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free